Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system

• Raymond K. Cross ,

  Roles Conceptualization, Methodology, Writing – review & editing

  * E-mail: rcross@medicine.umaryland.edu

  Affiliation University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  http://orcid.org/0000-0001-9766-5196

  ⨯
• Michael Chiorean,

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation Virginia Mason Medical Center, Seattle, Washington, United States of America

  ⨯
• Francis Vekeman,

  Roles Conceptualization, Data curation, Formal analysis, Methodology, Validation, Writing – review & editing

  Affiliation Groupe d’analyse, Ltée, Montréal, Québec, Canada

  ⨯
• Yongling Xiao,

  Roles Data curation, Formal analysis, Methodology, Validation, Writing – review & editing

  Affiliation Groupe d’analyse, Ltée, Montréal, Québec, Canada

  ⨯
• Eric Wu,

  Roles Data curation, Methodology, Writing – review & editing

  Affiliation Analysis Group, Inc., Boston, Massachusetts, United States of America

  ⨯
• Jingdong Chao,

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation AbbVie Inc., North Chicago, Illinois, United States of America

  ⨯
• Anthony W. Wang

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation AbbVie Inc., North Chicago, Illinois, United States of America

  http://orcid.org/0000-0002-7551-4730

  ⨯